Highstreet Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Highstreet Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.55M	Buy	+24,221	New	+$1.39M	0.07%	109
2018 Q2	–	Sell	-258	Closed	-$16K	–	278
2018 Q1	$16K	Buy	+258	New	+$16.6K	﹤0.01%	281
2016 Q1	–	Sell	-81,902	Closed	-$5.63M	–	158
2015 Q4	$5.63M	Buy	81,902 +60,921	+290%	+$4.03M	1.2%	25
2015 Q3	$1.24M	Buy	20,981 +794	+4%	+$50.4K	0.41%	69
2015 Q2	$1.34M	Buy	+20,187	New	+$1.33M	0.39%	75

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Highstreet Asset Management's BMY Position: Q4 2019 in Review

Highstreet Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q4 2019: 24,221 shares worth $1.55M. The stake represents 0.07% of the portfolio and ranks #109 among its holdings. This is a return to the name: Highstreet Asset Management previously reported a position in BMY as recently as Q1 2018.

Highstreet Asset Management first reported a position in BMY in Q2 2015 and has held it in 5 quarters since. The position peaked at $5.63M in Q4 2015. 2,218 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

Highstreet Asset Management held 24,221 shares of Bristol-Myers Squibb worth $1.55M as of Q4 2019.
Bristol-Myers Squibb was a new Highstreet Asset Management position in Q4 2019.
Bristol-Myers Squibb made up 0.07% of Highstreet Asset Management's portfolio in Q4 2019, its #109 holding.
Highstreet Asset Management first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 5 quarters since.
Highstreet Asset Management's Bristol-Myers Squibb position peaked at $5.63M in Q4 2015.
2,218 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Highstreet Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.